Black Rock Inc. Psychemedics Corp Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Psychemedics Corp stock. As of the latest transaction made, Black Rock Inc. holds 71,019 shares of PMD stock, worth $149,139. This represents 0.0% of its overall portfolio holdings.

Number of Shares

71,019

Previous 76,748 7.46%

Holding current value

$149,139

Previous $224,000 23.66%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$2.25 - $2.88 $12,890 - $16,499	-5,729 Reduced 7.46%	71,019 $171,000
Q1 2024 May 10, 2024	SELL	$2.92 - $3.79 $1,515 - $1,967	-519 Reduced 0.67%	76,748 $224,000
Q4 2023 Feb 13, 2024	SELL	$2.06 - $3.69 $234 - $420	-114 Reduced 0.15%	77,267 $228,000
Q3 2023 Nov 13, 2023	SELL	$3.66 - $5.05 $1,460 - $2,014	-399 Reduced 0.51%	77,381 $307,000
Q2 2023 Aug 11, 2023	SELL	$4.55 - $5.6 $1,815 - $2,234	-399 Reduced 0.51%	77,780 $354,000
Q1 2023 May 12, 2023	SELL	$4.93 - $6.47 $39,868 - $52,322	-8,087 Reduced 9.37%	78,179 $410,000
Q4 2022 Feb 13, 2023	SELL	$4.9 - $6.7 $828 - $1,132	-169 Reduced 0.2%	86,266 $422,000
Q3 2022 Nov 14, 2022	SELL	$6.08 - $6.84 $3,477 - $3,912	-572 Reduced 0.66%	86,435 $557,000
Q2 2022 Aug 12, 2022	SELL	$6.1 - $7.04 $8,594 - $9,919	-1,409 Reduced 1.59%	87,007 $552,000
Q1 2022 May 12, 2022	SELL	$6.49 - $7.56 $14,122 - $16,450	-2,176 Reduced 2.4%	88,416 $609,000
Q4 2021 Feb 10, 2022	BUY	$6.86 - $8.79 $6,695 - $8,579	976 Added 1.09%	90,592 $637,000
Q3 2021 Nov 09, 2021	BUY	$6.31 - $8.4 $18 - $25	3 Added 0.0%	89,616 $752,000
Q2 2021 Aug 11, 2021	BUY	$6.25 - $8.25 $560,081 - $739,307	89,613 New	89,613 $625,000

Others Institutions Holding PMD

# of Institutions

Shares Held

91.3K

Call Options Held

Put Options Held

View Full List

About PSYCHEMEDICS CORP

Ticker PMD
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 5,626,200
Market Cap $11.8M
Description
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, ...

More about PMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account